Clinical trial
Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal Crohn's Disease: A Phase II Randomized Trial
NCT07680283 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal Crohn's Disease: A Phase II Randomized Trial
- Lead sponsor
- The Cleveland Clinic
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 30, 2026
- Completion date
- January 31, 2029
- Enrollment
- 22 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease (cd)